{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:49:50Z","timestamp":1765975790093,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.eplepsyres.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T04:46:57Z","timestamp":1247287617000},"page":"163-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model"],"prefix":"10.1016","volume":"86","author":[{"given":"Ewa","family":"Wojda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Wlaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarogniew J.","family":"Luszczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2009.06.003_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eplepsyres.2003.08.001","article-title":"Comparison of the effect of glutamate receptor modulators in the 6Hz and maximal electroshock seizure models","volume":"56","author":"Barton","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action tranquilisante: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp. (Basle)"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)05160-2","article-title":"Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test","volume":"107","author":"Brown","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(02)00257-7","article-title":"Current limitations of antiepileptic drug therapy: a conference review","volume":"53","author":"Deckers","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eplepsyres.2007.04.008","article-title":"Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"75","author":"Donato Di Paola","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib9","doi-asserted-by":"crossref","unstructured":"Dudra-Jastrzebska, M., Andres-Mach, M.M., Ratnaraj, N., Patsalos, P.N., Czuczwar, S.J., Luszczki, J.J. Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model. Seizure, doi:10.1016\/j.seizure.2009.06.009, in press.","DOI":"10.1016\/j.seizure.2009.06.009"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.12.046","article-title":"Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis","volume":"605","author":"Dudra-Jastrzebska","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(95)00077-1","article-title":"Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy","volume":"22","author":"Gower","year":"1995","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90855-X","article-title":"Ucb L059, a novel anti-convulsant drug: pharmacological profile in animals","volume":"222","author":"Gower","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","article-title":"Towards a mechanism-based analysis of pharmacodynamic drug\u2013drug interactions in vivo","volume":"106","author":"Jonker","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0013-9580.2004.50503.x","article-title":"Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat","volume":"45","author":"Jonker","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2006.00952.x","article-title":"Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?","volume":"48","author":"Jonker","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1528-1167.2008.01713.x","article-title":"Benefits of combination therapy in epilepsy: a review of preclinical evidence with levetiracetam","volume":"50","author":"Kaminski","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib22","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"L\u00f6scher","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-007-0144-z","article-title":"Isobolographic analysis of interaction between drugs with nonparallel dose\u2013response relationship curves: a practical application","volume":"375","author":"Luszczki","year":"2007","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00210-008-0305-8","article-title":"Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves","volume":"378","author":"Luszczki","year":"2008","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.euroneuro.2005.03.005","article-title":"Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice","volume":"15","author":"Luszczki","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2006.00364.x","article-title":"Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis","volume":"47","author":"Luszczki","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1528-1167.2006.00964.x","article-title":"Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model","volume":"48","author":"Luszczki","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"Luszczki","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1528-1157.2003.32702.x","article-title":"Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis","volume":"44","author":"Luszczki","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib34","first-page":"1001","article-title":"Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis","volume":"44","author":"Luszczki","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2003.08.003","article-title":"Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics\u2014a comparative study","volume":"56","author":"Luszczki","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-004-0867-z","article-title":"Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study","volume":"369","author":"Luszczki","year":"2004","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.0013-9580.2004.05104.x","article-title":"Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis","volume":"45","author":"Luszczki","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib38","first-page":"782","article-title":"How significant is the difference between drug doses influencing the threshold for electroconvulsions?","volume":"57","author":"Luszczki","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00210-006-0100-3","article-title":"Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis","volume":"374","author":"Luszczki","year":"2006","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pnpbp.2006.11.020","article-title":"Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy","volume":"31","author":"Luszczki","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yebeh.2005.07.007","article-title":"Pharmacodynamic and\/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"7","author":"Luszczki","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2008.07.051","article-title":"Isobolographic and behavioral characterizations of interactions between vigabatrin and gabapentin in two experimental models of epilepsy","volume":"595","author":"Luszczki","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00210-008-0349-9","article-title":"Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model","volume":"379","author":"Luszczki","year":"2009","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.brainresbull.2008.07.006","article-title":"Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats","volume":"77","author":"Margineanu","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2007.05.008","article-title":"Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA\/2J mice","volume":"75","author":"Marrosu","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam\u2013diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib48","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib50","first-page":"31","article-title":"Pharmacological principles as a basis for polytherapy","volume":"162","author":"Perucca","year":"1995","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1059-1311(03)00185-7","article-title":"Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models","volume":"13","author":"Sills","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00309-6","article-title":"Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction","volume":"48","author":"Sisodiya","year":"2002","journal-title":"Epilepsy Res."},{"year":"2000","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","key":"10.1016\/j.eplepsyres.2009.06.003_bib53"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2006.08.002","article-title":"Interactions between drugs and occupied receptors","volume":"113","author":"Tallarida","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib56","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.1.11-12.444","article-title":"Neuropharmacologic considerations in psychic seizures","volume":"1","author":"Toman","year":"1951","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib57","first-page":"96","article-title":"The search for new drugs against epilepsy","volume":"10","author":"Toman","year":"1952","journal-title":"Tex. Rep. Biol. Med."},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib58","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2009.06.003_bib59","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1167.2008.01594.x","article-title":"Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model","volume":"49","author":"Vinogradova","year":"2008","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:21:40Z","timestamp":1760275300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121109001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":59,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0920121109001624"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.06.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6Hz psychomotor seizure model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}